Trial intelligence / Profile preview

Sildenafil for prevention of acute kidney injury after cardiac surgery

ISRCTN18386427Phase 2Completed

Sponsor
University of Leicester
Start
Jan 2016
Modality
Small Molecules
01

Overview

Phase 2, randomised trial in acute kidney failure (AKF) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Serum creatinine. Started Jan 2016; status: completed.

02

Drugs

sildenafil
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on ISRCTN18386427.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN18386427.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call